Fatemeh Rezaei-Tazangi

Dr. Fatemeh Rezaei-Tazangi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2022 in Pharmacology
Verified
Journal Article
Closed access
PDF file
FSFaezeh Samadi
Faezeh Samadi
MKMohammad Saeed Kahrizi
Mohammad Saeed Kahrizi
FHFateme Heydari
Fateme Heydari
RAReza Arefnezhad
Reza Arefnezhad
HRHossein Roghani-Shahraki
Hossein Roghani-Shahraki
FRFatemeh Rezaei-Tazangi
Fatemeh Rezaei-Tazangi
Background: Osteoarthritis (OA), as one of the chronic debilitating conditions, affects 15% of people globally and is linked with serious problems, such as cardiovascular diseases, metabolic syndrome, and autoimmune inflammatory disorders. The current therapeutic options for this disease include nonsteroidal anti-inflammatory drugs, surgery, gene therapy, intrasynovial gel injection, and warm needle penetration. However, these approaches may be accompanied by considerable side effects, high costs, and some limitations for patients. Thus, using an alternative way is needed. Summary: Presently, natural compounds based-therapies, like flavonoids, have acquired much attention in the current era. One of the compounds belonging to the flavonoid family is quercetin, and its therapeutic effects on disorders related to joints and cartilage have been addressed in vivo and in vitro studies. Key Messages: In this review, we summarized evidence indicating its curative capacity against OA with a mechanistic insight.

17 December 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
FRFatemeh Rezaei-Tazangi
Fatemeh Rezaei-Tazangi
HRHossein Roghani-Shahraki
Hossein Roghani-Shahraki
MGMahdi Khorsand Ghaffari
Mahdi Khorsand Ghaffari
FZFiroozeh Abolhasani Zadeh
Firoozeh Abolhasani Zadeh
ABAynaz Boostan
Aynaz Boostan
HMHossein Motedayyen
Hossein Motedayyen
Ovarian cancer (OCa) is characterized as one of the common reasons for cancer-associated death in women globally. This gynecological disorder is chiefly named the “silent killer” due to lacking an association between disease manifestations in the early stages and OCa. Because of the disease recurrence and resistance to common therapies, discovering an effective therapeutic way against the disease is a challenge. According to documents, some popular herbal formulations, such as curcumin, quercetin, and resveratrol, can serve as an anti-cancer agent through different mechanisms. However, these herbal products may be accompanied by some pharmacological limitations, such as poor bioavailability, instability, and weak water solubility. On the contrary, using nano-based material, e.g., nanoparticles (NPs), micelles, liposomes, can significantly solve these limitations. Therefore, in the present study, we will summarize the anti-cancer aspects of these herbal and-nano-based herbal formulations with a focus on their mechanisms against OCa.

30 January 2023 in Cell Biology International
Verified
Journal Article
Closed access
RAReza ArefNezhad
Reza ArefNezhad
FRFatemeh Rezaei-Tazangi
Fatemeh Rezaei-Tazangi
HRHossein Roghani‐Shahraki
Hossein Roghani‐Shahraki
Pouya GoleijPouya Goleij
Pouya Goleij
NZNabi Zare
Nabi Zare
EAElaheh Aghazadeh
Elaheh Aghazadeh

11 April 2025 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
ACAmir Modarresi Chahardehi
Amir Modarresi Chahardehi
NFNiki Faraji
Niki Faraji
NENikoo Emtiazi
Nikoo Emtiazi
RNReza Nasiri
Reza Nasiri
MDMaryam Daghagheleh
Maryam Daghagheleh
MTMarziye Ranjbar Tavakoli
Marziye Ranjbar Tavakoli
Brain tumors provide considerable diagnostic and treatment challenges due to their intricate nature and the hazards linked to direct tissue biopsies. Owing to the restricted sensitivity and specificity of conventional procedures, new techniques like liquid biopsy have garnered attention. Circulating tumor DNA (ctDNA), present in physiological fluids such as cerebrospinal fluid (CSF) and plasma, has emerged as a viable instrument for non-invasive tumor characterization. Hence, advancements in next-generation sequencing (NGS) and digital PCR have enhanced the sensitivity of ctDNA detection, rendering it a feasible method for monitoring tumor dynamics and evaluating therapy responses. Research indicates that ctDNA strongly correlates with tumor heterogeneity, providing a superior alternative to single-site tissue biopsies. CSF, due to its proximity to the brain, offers elevated amounts of ctDNA for examination relative to plasma, particularly in central nervous system (CNS) cancers. Research indicates that ctDNA can detect actionable mutations, forecast little residual illness, and enable real-time monitoring of disease development and resistance. Notwithstanding these advantages, difficulties, including poor ctDNA yield and heterogeneity in detection methodologies persist. This review examines the clinical efficacy of ctDNA in brain tumor diagnosis, emphasizes technical developments in ctDNA analysis, and stresses the necessity for standardized methods. Comprehending the capabilities and constraints of ctDNA can facilitate the development of more accurate, individualized therapy approaches in neuro-oncology.

27 February 2024 in Cell Biology International
Verified
Journal Article
Closed access
RAReza Arefnezhad
Reza Arefnezhad
SASara Ashna
Sara Ashna
FRFatemeh Rezaei-Tazangi
Fatemeh Rezaei-Tazangi
SASeyed Mahdi Arfazadeh
Seyed Mahdi Arfazadeh
SSSeyede Shabnam Seyedsalehie
Seyede Shabnam Seyedsalehie
Massoud VosoughMassoud Vosough
Massoud Vosough

18 May 2024 in Tissue and Cell
Verified
Journal Article
Closed access
RAReza Arefnezhad
Reza Arefnezhad
MHMaryam Helfi
Maryam Helfi
RORana Okhravijouybari
Rana Okhravijouybari
PGPouya Goleij
Pouya Goleij
MSMaral Sargolzaeimoghaddam
Maral Sargolzaeimoghaddam
ANAhmad Nazari
Ahmad Nazari